Cargando…

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa

Introduction: Whether intramuscular depot medroxyprogesterone acetate (DMPA-IM) and norethisterone enanthate (NET-EN) have a differential impact on the incidence of sexually transmitted infection (STI) remains unclear. In the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial, HIV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noguchi, Lisa M., Marrazzo, Jeanne M., Richardson, Barbara, Hillier, Sharon L., Balkus, Jennifer E., Palanee-Phillips, Thesla, Nair, Gonasagrie, Panchia, Ravindre, Piper, Jeanna, Gomez, Kailazarid, Ramjee, Gita, Chirenje, Z. Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Reproductive Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165437/ https://www.ncbi.nlm.nih.gov/pubmed/35669097 http://dx.doi.org/10.3389/frph.2021.668685

Ejemplares similares

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
por: Balkus, Jennifer E., et al.
Publicado: (2016)

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial
por: Riddler, Sharon A., et al.
Publicado: (2017)

Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High‐risk African Women
por: Kiweewa, Flavia Matovu, et al.
Publicado: (2019)

Editorial: Integration of HIV prevention with sexual and reproductive health services
por: Palanee-Phillips, Thesla
Publicado: (2023)

Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study
por: van der Straten, Ariane, et al.
Publicado: (2016)

Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review
por: Bhushan, Nivedita L., et al.
Publicado: (2023)

Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives
por: Achilles, Sharon L., et al.
Publicado: (2020)

Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections
por: Dabee, Smritee, et al.
Publicado: (2023)

Effects of prolonging the interval from progestin removal to prostaglandin F(2α) injection from 16 to 17 d in a long-term estrus synchronization protocol in beef heifers()
por: Oosthuizen, Nicola, et al.
Publicado: (2021)

The Impact of Progestin-only Contraception on Adolescents with Macromastia
por: Nuzzi, Laura C., et al.
Publicado: (2021)

Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
por: Lokken, Erica M., et al.
Publicado: (2021)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial
por: Beksinska, Mags, et al.
Publicado: (2021)

Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa
por: Leslie, Jonah, et al.
Publicado: (2021)

“Antibiotics Can Work as a Contraceptive:” Contraceptive Knowledge and Use Among University Students in Calabar, Nigeria
por: Asaolu, Ibitola, et al.
Publicado: (2021)

Common ground: the opportunity of male contraceptives as MPTs
por: Vahdat, Heather L., et al.
Publicado: (2023)

The association of host genes with specific sexually transmitted infections
por: Bovungana, Qhama, et al.
Publicado: (2023)

Need for Screening Triglyceride Levels in Women on Oral Contraceptives
por: Yau, Alice, et al.
Publicado: (2021)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe
por: Murombedzi, Caroline, et al.
Publicado: (2023)

Bacterial Vaginosis and Sexually Transmitted Infections in an HIV-Positive Cohort
por: Nava-Memije, Karina, et al.
Publicado: (2021)

Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans
por: Sarna, Magdalena A., et al.
Publicado: (2009)

Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception
por: Eriksson, Karin, et al.
Publicado: (2020)

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation
por: Shamseddin, Marie, et al.
Publicado: (2021)

Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol
por: Mazza, Danielle, et al.
Publicado: (2016)

Geographical Clustering of High Risk Sexual Behaviors in “Hot-Spots” for HIV and Sexually Transmitted Infections in Kwazulu-Natal, South Africa
por: Ramjee, Gita, et al.
Publicado: (2013)

Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models
por: Wand, Handan, et al.
Publicado: (2015)

‘In fact, that’s when I stopped using contraception’: a qualitative study exploring women’s experiences of using contraceptive methods in KwaZulu-Natal, South Africa
por: Hlongwa, Mbuzeleni, et al.
Publicado: (2023)

Commentary: Multipurpose prevention technologies—What about sexually transmitted infections?
por: Lu, Anjanique Mariquit Rosete, et al.
Publicado: (2023)

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control—plus more
por: Shoupe, Donna
Publicado: (2023)

Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa
por: Ramjee, Gita, et al.
Publicado: (2010)

Increasing the availability of long-acting reversible contraception and medical abortion in primary care: the Australian Contraception and Abortion Primary Care Practitioner Support Network (AusCAPPS) cohort study protocol
por: Mazza, Danielle, et al.
Publicado: (2022)

SAT-221 False-Positive Urinary Free Cortisol with Oral Contraceptive Use
por: Lavelle, Kristen, et al.
Publicado: (2019)

Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis
por: Milali, Masabho P., et al.
Publicado: (2023)

Health care provider bias in the Appalachian region: The frequency and impact of contraceptive coercion
por: Swan, Laura E. T., et al.
Publicado: (2023)

Contraceptive use and discontinuation among women aged 15–24 years in Kenya
por: Kungu, Wambui
Publicado: (2023)

A rodent model of human dose-equivalent progestin-only implantable contraception
por: Allaway, Heather C. M., et al.
Publicado: (2021)

Enhanced ZBTB16 Levels by Progestin-Only Contraceptives Induces Decidualization and Inflammation
por: Arlier, Sefa, et al.
Publicado: (2023)

SAT-220 Oral Contraceptives and Their Effect on the Evaluation of Cushing's Syndrome: A Case Report
por: Ng, Zhi Guang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jmkeufuati9hlum7tbk0t1gfd1